Board
Screen
Heat
Cal
Watch
News
Blog
TV
Home
/
ORKA
Home
/
ORKA

NASDAQ
$101.41
$101.41

Overview

Price performance
Low
$96.34
High
$102.59
After hours. Last updated: Nov 4, 2026, 9:00 PM UTC
$
101.41
1.86 (1.87%)
Average, 50 days
$88.17
$69.88
Open
$102.37
Previous close
$99.55
52-week high
$115.52
Aug 19, 2026 (3 months ago)
52-week low
$25.23
Jan 5, 2026 (11 months ago)
301.94%

Valuation & Estimates

Earnings

Financials

Insider Trading

Peer Analysis

Insights & Activity

Market Cap
6.71B
Volume
789 995
Total Return (3M)
3.34%
Total Return (1Y)
269.70%
—
Sector
Healthcare
Links
Tags
Healthcare
Biotechnology
NASDAQ
US
Website
orukatx.com
About
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.

Frequently asked questions

ORKA · Oruka Therapeutics, Inc.

01What is Oruka Therapeutics, Inc. stock price today?

The current price of ORKA is $101.41 — it has increased by 1.87% since the previous close. Data as of Nov 4, 2026.

02Is Oruka Therapeutics, Inc. stock price growing?

ORKA is up 6.89% over the past week, up 19.98% over the past month and up 269.70% over the past year. The price is above its 200-day moving average of $69.88.

03What is ORKA stock forecast?

Analysts' average 12-month price target for ORKA is $137.50, which implies 35.59% upside from the current price. Individual estimates range from $120.00 to $180.00.

04What do analysts say about ORKA stock?

Of the 13 analysts covering Oruka Therapeutics, Inc., 2 rate it a strong buy and 11 rate it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.

05What is Oruka Therapeutics, Inc. market cap?

Oruka Therapeutics, Inc. has a market capitalization of $6.71B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

06What were Oruka Therapeutics, Inc. earnings last quarter?

In its most recent quarterly report, Oruka Therapeutics, Inc. posted a loss of $0.55 per share against an estimate of -$0.5125, missing expectations by 7.32%. Upcoming reports are listed in the earnings calendar.

07Does Oruka Therapeutics, Inc. pay dividends?

Oruka Therapeutics, Inc. has not paid any dividends over the past year.

08How volatile is ORKA stock?

In the latest trading session ORKA moved between $96.34 and $102.59, a range of 6.16% of its current price.

09Should I invest in Oruka Therapeutics, Inc. stock?

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Oruka Therapeutics, Inc. shows a strong buy rating today and a buy rating on the weekly timeframe. Technical ratings are indicators, not investment advice.

10What are ORKA stock 52-week high and low?

Over the past 52 weeks ORKA has traded between $25.23 and $115.52. The current price is 12.21% below its 52-week high.

Figures as of Nov 4, 2026. This information is provided for general purposes only and is not investment advice.